RTW Fund Group GP, LLC
CIK: 0002147397
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
YARW
Yarrow Bioscience, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About RTW Fund Group GP, LLC
RTW Fund Group GP, LLC (SEC CIK 0002147397) files insider reports with the SEC as 10% Owner of Yarrow Bioscience, Inc. (YARW).
Signal8 holds 2 ownership filings by RTW Fund Group GP, LLC (1 Form 3, 1 Form 4), filed on Jul 30, 2026. Those filings report 1 transaction, the latest on Jul 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on RTW Fund Group GP, LLC's filings is in NEW YORK, NY.
Recent filings by RTW Fund Group GP, LLC
- Jul 29, 2026: Other transaction of YARW shares (Form 4, code J).
Other insiders filing for Yarrow Bioscience, Inc. (YARW)
- Payton Lori, Chief Development Officer
- Alford Rachael, Chief Operating Officer
- Frey Rebecca, Chief Executive Officer
- Ryder Steven, Chief Medical Officer
- Zeronda Tyler, Chief Financial Officer
- Ashiya Mona, Director